Preconditioning with fludarabine, busulfan and cytarabine versus standard BuCy2 for patients with acute myeloid leukemia: a prospective, randomized phase II study

Preconditioning with fludarabine, busulfan and cytarabine versus standard BuCy2 for patients with acute myeloid leukemia: a prospective, randomized phase II studyPreconditioning with fludarabine, busulfan and cytarabine versus standard BuCy2 for patients with acute myeloid leukemia: a prospective, randomized phase II study, Published online: 19 October 2018; doi:10.1038/s41409-018-0356-5Preconditioning with fludarabine, busulfan and cytarabine versus standard BuCy2 for patients with acute myeloid leukemia: a prospective, randomized phase II study

https://www.nature.com/articles/s41409-018-0356-5

Source: Bone Marrow Transplantation - October 19, 2018 Category: Hematology Authors: Wei-Ping Zhang Zi-Wei Wang Xiao-Xia Hu Jie Chen Dan Yang Xian-Min Song Lei Gao Xiong Ni Li Chen Xin-Xin Xia Hong Zhou Gu-Sheng Tang Hui Cheng Yan-Rong Luo Hong-Mei Li Jian-Min Yang Jian-Min Wang Source Type: research